Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex vaccines could renew the innovation engine.
{iframe}https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/refueling-the-innovation-engine-in-vaccines?cid=other-eml-alt-mip-mck&hlkid=c19e7d5ae6eb4892abf77940d356e437&hctky=3027237&hdpid=288e4a9a-fa67-4cbc-ba86-64b061a1d421{/iframe}